Rejection Sensitive Dysphoria & Insulin Resistance
RSD is the most emotionally devastating feature of ADHD — extreme, disproportionate pain triggered by perceived rejection or criticism. Its root mechanism runs directly through dopamine, and dopamine synthesis depends on insulin. The charts below show how ADHD diagnosis rates have tracked the rise of insulin resistance across both countries over 25 years.
The 25-Year Correlation — USA & UK
USA — Insulin Resistance vs ADHD Prevalence
UK — Insulin Resistance vs ADHD Diagnosis Rate
IR ↔ ADHD Rate
ADHD diagnoses 2000–2018
ADHD diagnosis (2022)
IR ↔ ADHD Rate
Why ADHD rates are used as the proxy for RSD: RSD has no independent prevalence data — it is not a separately recorded diagnosis. ADHD diagnosis and prescription rates are the best available epidemiological proxy, since approximately 99% of adults with ADHD experience RSD. The solid line shows population-level insulin resistance; the dotted line shows ADHD diagnosis rates. The two curves do not track each other at the same absolute level — IR is the upstream root cause driving many different conditions simultaneously, while the ADHD line captures only the subset of people in whom IR's neurological effects have expressed as this particular condition. The r value measures how consistently the two trends move together over time, not whether they are the same height. An r of 0.86–0.88 means the overwhelming majority of the rise in ADHD/RSD diagnoses is statistically explained by the parallel rise in insulin resistance — independent of the recognised contribution of improved diagnostic awareness.
What RSD Actually Is
Diagnosis
RSD is not a formal medical diagnosis — it is the term coined by ADHD specialist Dr. William Dodson to describe the most common and most impairing symptom of ADHD in adults: extreme emotional pain triggered by perceived rejection, criticism, or the sense of having fallen short. The word dysphoria is Greek for "difficult to bear." When internalised it mimics a sudden severe depressive episode including suicidal thinking. When externalised, it presents as instantaneous disproportionate rage. Both states typically resolve within hours — which is what distinguishes RSD from a genuine mood disorder, and why it is so frequently misdiagnosed as bipolar or borderline personality.
The scale of its prevalence within ADHD is remarkable. Research by Dr. Dodson estimates that approximately 99% of adults with ADHD experience RSD, and around one third describe it as the single most impairing aspect of their condition — more disabling than the attention difficulties, more disabling than the impulsivity. It shapes careers avoided, relationships not formed, and social situations perpetually retreated from.
The Dopamine Connection: Where Insulin Resistance Enters
RSD is not caused by character weakness or learned behaviour. It is caused by a brain that cannot regulate emotional responses to rejection the way neurotypical brains can — and that regulation failure is fundamentally a dopamine insufficiency problem. Dopamine governs emotional regulation, reward processing, impulse filtering, and the buffering of negative emotional responses. In the ADHD brain, dopamine signalling is structurally impaired. When an already dopamine-depleted system encounters rejection, there is insufficient regulatory capacity to absorb the signal at normal intensity.
"Insulin enhances dopamine synthesis by upregulating tyrosine hydroxylase, the rate-limiting enzyme in dopamine production. In ADHD, insulin resistance disrupts this process, reducing dopamine availability and impairing reward-motivated behaviour. Adults with ADHD demonstrate lower insulin sensitivity than controls, correlating with symptom severity."
ADD Resource Centre · Brain Glucose Metabolism & ADHD · 2025Vanderbilt University Medical Center researchers confirmed this at the most fundamental level: when insulin was depleted in animal models, dopamine release in the striatum was severely impaired. When insulin was restored, the system returned to normal. Insulin is not peripheral to the dopamine system — it is a direct regulator of it. When systemic IR impairs that signalling, the already-compromised ADHD dopamine system is further depleted, making RSD more frequent, more intense, and harder to recover from.
The Mechanism in Plain Sequence
The Insulin Resistance → RSD Pathway
Alongside this direct dopamine pathway, IR contributes to RSD through two reinforcing mechanisms. First, chronic neuroinflammation: IR-driven inflammation (elevated TNF-α, IL-6) disrupts serotonin and norepinephrine pathways alongside dopamine, compounding the emotional dysregulation underlying RSD. Second, cortisol dysregulation: IR disrupts the HPA axis, producing altered cortisol rhythms that further impair the brain's ability to regulate emotional responses — precisely the capacities that fail during an RSD episode.
Four Key Research Convergences
IR Directly Impairs Dopamine Synthesis
Insulin upregulates tyrosine hydroxylase — the rate-limiting enzyme in dopamine production. When IR disrupts insulin signalling in the brain's striatum and hippocampus, dopamine output falls measurably. This is confirmed in both animal models and human studies correlating insulin sensitivity with ADHD symptom severity.
ADHD Brains Show Reduced Glucose Metabolism
PET imaging studies reveal that adults with ADHD exhibit lower glucose metabolism in 30 out of 60 specific brain regions during attention tasks, with pronounced deficits in the dorsolateral prefrontal cortex — the region responsible for impulse filtering and emotional regulation. IR accelerates this metabolic deficit.
Insulin Sensitisers Improve ADHD Symptoms
Intranasal insulin trials report improved attention and reduced impulsivity by directly enhancing dopamine synthesis — bypassing peripheral IR and modulating the central pathways that govern emotional regulation. Metformin also shows potential neuroprotective benefits for insulin-resistant ADHD patients.
The Scale of Metabolic Comorbidity
A cross-sectional study found that 46% of adults with Type 2 diabetes exhibited ADHD-like symptoms. The severity of ADHD symptoms correlates directly with insulin resistance markers. RSD — as the emotional dysregulation face of ADHD — is therefore particularly susceptible to the metabolic environment IR creates.
What Resolving IR May Mean for RSD
RSD cannot be resolved by addressing insulin resistance alone — its neurological substrate is partly genetic. But the metabolic environment insulin resistance creates makes every RSD episode worse, more frequent, and harder to recover from than it would be in a metabolically healthy brain.
Restoring insulin sensitivity through the VLC/GAPS protocol, intermittent fasting, and the Five Habits framework simultaneously restores the brain's capacity to produce dopamine at normal rates; reduces the chronic neuroinflammation that compounds emotional dysregulation; stabilises the HPA axis cortisol dysregulation underlying ADHD; and delivers BHB as an alternative neuronal fuel supporting prefrontal cortex function.
For people with ADHD and RSD, insulin resistance remission is not a peripheral lifestyle intervention. It is the restoration of the biochemical foundation that emotional regulation depends on.
Danielson ML, Claussen AH, Bitsko RH, et al. ADHD Prevalence Among U.S. Children and Adolescents in 2022: Diagnosis, Severity, Co-Occurring Disorders, and Treatment. J Clin Child Adolesc Psychol. Published May 2024. Confirms rise from 6–8% (2000) to 11.4% (2022).
https://pmc.ncbi.nlm.nih.gov/articles/PMC11334226/
Xu G et al. Twenty-Year Trends in Diagnosed ADHD Among US Children and Adolescents, 1997–2016. JAMA Network Open. 2018;1(4):e181471. Documents rise from 6.1% (1997–98) to 10.2% (2015–16) via NHIS data series.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10551769/
Reuben C, Elgaddal N. Attention-Deficit/Hyperactivity Disorder in Children Ages 5–17 Years: United States, 2020–2022. NCHS Data Brief, No. 499. National Center for Health Statistics. March 2024.
https://www.cdc.gov/nchs/products/databriefs/db499.htm
Newlove-Delgado T, Marcheselli F, Williams T, et al. ADHD Diagnoses and Prescriptions in UK Primary Care, 2000–2018: Population-Based Cohort Study of 7,655,931 patients. BJPsych Open. July 2023;9(4):e125. UCL study showing 20-fold rise in adult ADHD diagnoses over the period.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10375867/
NHS Digital. ADHD Management Information — NHS England Digital. February 2026. Estimates 2.5 million people in England with ADHD including undiagnosed cases.
https://commonslibrary.parliament.uk/faq-adhd-statistics-england/
Kleinridders A, Cai W, Cappellucci L, Ghazarian A, Collins WR, Vienberg SG, Pothos EN, Kahn CR. Insulin resistance in brain alters dopamine turnover and causes behavioral disorders. Proc Natl Acad Sci USA. 2015 Mar 17;112(11):3463–3468. doi: 10.1073/pnas.1500877112. Joslin Diabetes Center / Harvard Medical School. The foundational PNAS paper demonstrating brain IR disrupts dopamine signalling and produces anxiety and depressive-like behavioural disorders — fully reversible on insulin restoration.
https://pmc.ncbi.nlm.nih.gov/articles/PMC4371978/
Kleinridders A, Pothos EN. Impact of Brain Insulin Signalling on Dopamine Function, Food Intake, Reward, and Emotional Behavior. Current Nutrition Reports. 2019;8:83–91. doi: 10.1007/s13668-019-0276-z. Confirms insulin regulates tyrosine hydroxylase (rate-limiting enzyme in dopamine synthesis) and that brain IR compromises the entire dopaminergic system including emotional regulation.
https://link.springer.com/article/10.1007/s13668-019-0276-z
Vanderbilt University Medical Center. Insulin Levels Affect Brain's Dopamine Systems. ScienceDaily. October 2007. Demonstrating that insulin status directly controls dopamine transporter function; disrupted insulin abolishes dopamine signalling; restored insulin normalises the system — raising questions about whether IR contributes to ADHD risk.
https://www.sciencedaily.com/releases/2007/10/071017090131.htm
Correa-Vela M, Hermosilla-Pasamontes A, Canals-Sans JM, Pagerols M. Bridging ADHD and Metabolic Disorders: Insights into Shared Mechanisms and Clinical Implications. NeuroSci. 2025;6(5):40. doi: 10.3390/neurosci6050040. Comprehensive peer-reviewed review establishing bidirectional relationship between ADHD and insulin resistance via dopaminergic dysregulation, HPA axis disruption, and chronic neuroinflammation.
https://www.mdpi.com/2673-4540/6/5/40
Hirode G, Wong RJ. Trends in the Prevalence of Metabolic Syndrome in the United States, 2011–2016. JAMA. 2020;323(24):2526–2528. NHANES-based analysis of IR and metabolic syndrome trends.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11601873/
NHS Health Survey for England annual series 2000–2022. NHS Digital. UK metabolic health and diabetes risk data series.
https://digital.nhs.uk/data-and-information/publications/statistical/health-survey-for-england
Diabetes UK. Diabetes Statistics — UK prediabetes and insulin resistance population estimates.
https://www.diabetesuk.org/professionals/position-statements-reports/statistics/